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This data article presents data associated with the research article
entitled “Evaluation of cell-laden polyelectrolyte hydrogels incor-
porating poly(L-lysine) for applications in cartilage tissue engineer-
ing” (Lam et al., 2016) [1]. Synthetic hydrogel composites fabricated
using oligo(poly(ethylene glycol) fumarate) (OPF) macromers were
utilized as vehicles for the incorporation of poly(L-lysine) (PLL) as
well as the encapsulation of mesenchymal stem cells (MSCs). PLL-
laden and PLL-free hydrogels were fabricated to characterize the
main and interaction effects of OPF molecular weight, PLL molecular
weight, and PLL loading density on the swelling and degradation of
synthetic OPF hydrogels. Cells were then encapsulated within such
hydrogels for in vitro culture and examined for viability, biochemical
activity, and chondrogenic gene expression. These data, which are
supplementary to the associated research article (Lam et al., 2016) [1],
are presented here.
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.biomaterials.2016.01.020
ing Rice University P.O. Box 1892, MS-142 Houston, TX 77251-1892.
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Table 1
Full factorial study to charac
Levels (n¼4) (
Hi 2
Lo 5Speciﬁcations Tableubject area Polymer chemistry, tissue engineering, regenerative medicine, biology
ore speciﬁc sub-
ject areaHydrogel, biomaterials, mesenchymal stem cell, cartilage tissue engineeringype of data Table, ﬁgure
ow data was
acquiredMass balance, microscopyata format Figure is raw, table is analyzed
xperimental
factorsFactorial study details in Table 1xperimental
featuresSwelling ratio and degradation of hydrogels were derived from comparing
the mass of swollen and dried hydrogels; main effects analysis was per-
formed to identify both main and interaction effects of PLL loading para-
meters on hydrogel swelling and degradation; the LIVE/DEAD image was
obtained from cell-laden, PLL-laden hydrogelsata source
locationHouston, Texas, USAata accessibility Data is provided in the articleValue of the data Data will be informative for the design of synthetic hydrogels incorporating charged biomacro-
molecules (i.e. poly(L-lysine)) for stimulating phenotypic changes in co-encapsulated stem cells for
applications in tissue engineering [1].
 Data from the full factorial analysis can help identify important fabrication parameters to modulate
in order to control hydrogel swelling and degradation properties.1. Data
The data provided here for the hydrogel formulations from the full factorial design (Table 1)
represent the mean values for both the swelling ratio (Table 2) and the mass loss (%) (Table 3). Fol-
lowing these data are those describing the main and interaction effects of modulating hydrogel
fabrication factors (Table 1) on the swelling and degradation properties of the resultant constructs.
The cytocompatibility of the MSCs after encapsulation within PLL-laden OPF hydrogels is then shown
in Fig. 1.2. Experimental design, materials and methods
PLL-free 10 K and 35 K OPF hydrogels were utilized as negative controls. The nomenclature for the
experimental groups is as follows: (OPF MW)(PLL MW)(PLL Dosage).terize swelling behavior and degradation of PLL-laden hydrogels.
A) PLL MW (kDa) (B) PLL Dosage (per hydrogel) (C) OPF MW (g/mol)
25 20 mg 35 K
0 500 ng 10 K
Table 2
Mean swelling ratios of (a) 10 K and (b) 35 K OPF composite formulations.
Formulation PLL MW (kDa) PLL Dosage
(per hydrogel)
OPF MW
(g/mol)
Mean swelling ratio
Day 1 Day 7 Day 14 Day 28
a.)
10 K Control –– –– 10 K 15.270.7b 17.370.6b 14.471.4 20.370.6a,b
10 K 50Hi 50 20 mg 10 K 17.470.7a 17.870.4a,b 13.472.4 17.871.5c
10 K 50Lo 50 500 ng 10 K 16.771.3a,b 17.670.8a,b 14.271.4 20.770.4a
10 K 225Hi 225 20 mg 10 K 18.570.7a 16.970.6b 14.570.2 19.270.8a,b,c
10 K 225Lo 225 500 ng 10 K 17.770.9a 19.471.7a 12.471.8 18.471.2b,c
b.)
35 K Control –– –– 35 K 16.370.6c 20.370.0a 20.370.2a 29.371.7a
35 K 50Hi 50 20 mg 35 K 18.971.3a,b 20.670.6a 20.771.0a 23.270.6b,c
35 K 50Lo 50 500 ng 35 K 17.771.7b,c 18.570.4b 20.170.6a,b 19.773.0c
35 K 225Hi 225 20 mg 35 K 20.970.2a 18.370.2b 18.470.6b 22.172.5c
35 K 225Lo 225 500 ng 35 K 21.070.9a 18.670.6b 20.471.2a 27.070.7a,b
For each time point, values not connected by the same letters (a, b, or c) are signiﬁcantly different (po0.05).
Table 3
Mean Mass Loss (%) of (a) 10 K and (b) 35 K OPF composite formulations.
Formulation PLL MW (kDa) PLL Dosage
(per hydrogel)
OPF MW
(g/mol)
Mean mass loss (%)
Day 1 Day 7 Day 14 Day 28
a.)
10 K Control –– –– 10 K 55.470.6a,b 59.071.8a 49.674.5 60.170.4
10 K 50Hi 50 20 mg 10 K 55.973.9a 62.070.7a 52.474.8 62.377.9
10 K 50Lo 50 500 ng 10 K 46.773.0c 51.472.7b 48.378.0 63.470.8
10 K 225Hi 225 20 mg 10 K 53.773.1a,b 51.272.3b 52.677.8 68.371.3
10 K 225Lo 225 500 ng 10 K 49.472.4b,c 58.574.3a 47.772.6 60.373.7
b.)
35 K Control –– –– 35 K 46.573.3 59.271.4a 65.171.5 71.771.7
35 K 50Hi 50 20 mg 35 K 49.3713.9 52.573.0b 63.075.9 68.571.9
35 K 50Lo 50 500 ng 35 K 45.074.3 56.174.8a,b 62.770.7 64.375.3
35 K 225Hi 225 20 mg 35 K 49.672.8 59.771.3a 61.774.9 66.976.4
35 K 225Lo 225 500 ng 35 K 52.176.4 55.072.4a,b 55.477.6 67.477.0
For each time point, values not connected by the same letters (a, b, or c) are signiﬁcantly different (po0.05).
Fig. 1. Viability staining of cells using LIVE/DEAD is shown for (A) non-PLL-laden controls and (B) PLL-laden hydrogels (500 ng/
hydrogel) at 24 h and for (C) PLL-laden hydrogels (500 ng/hydrogel) at 7 days after cell encapsulation. Green: live cells, red:
dead cells; scale bar ¼ 200 mm.
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Table 4
Main and cross effects on the swelling behavior and degradation of PLL-laden hydrogels.
Swelling ratio
Time A B C AB BC AC ABC
Day 1 0.91770.366 0.32470.366 1.01070.366 0.16470.366 0.04870.366 0.41570.366 0.17270.366
Day 7 0.18370.284 0.05170.284 0.55070.284 0.63370.284 0.51870.284 0.38670.284 0.05170.284
Day 14 0.35270.474 0.00970.474 3.13970.474 0.03470.474 0.35170.474 0.16770.474 0.69870.474
Day 28 0.65370.565 0.43070.565 2.00370.565 0.58370.565 0.10470.565 0.88970.565 1.51470.565
Mass loss
Day 1 0.01070.011 0.01970.011 0.01270.011 0.01570.011 0.01570.011 0.00970.011 0.00270.011
Day 7 0.00370.005 0.00570.005 0.00070.005 0.01270.005 0.00370.005 0.01270.005 0.03370.005
Day 14 0.01170.010 0.01970.010 0.05270.010 0.00870.010 0.00370.010 0.01070.010 0.00770.010
Day 28 0.00570.009 0.01370.009 0.01670.009 0.00570.009 0.00470.009 0.00270.009 0.01770.009
(A), (B), and (C) refer to the factors of PLL MW, PLL Dosage, and OPF MW as outlined in Table 1, respectively. Bold indicates signiﬁcant main or cross effects (po0.05).
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J. Lam et al. / Data in Brief 7 (2016) 614–6196182.1. Swelling and degradation of PLL-laden OPF hydrogels
Swelling ratio (Table 2) and mass loss (Table 3) data, which were calculated by averaging the
measured swelling ratio and mass loss (%) values for each formulation (n¼4) at each time point over
28 days, respectively, were reported as the mean7standard deviation for samples at each time point.
Following previously established procedures [2–4], fabricated hydrogels for the swelling and degra-
dation study (n¼4) were placed in 2 mL of PBS (pH 7.4) in a 24 well plate and incubated at 37 °C and
under agitation (shaker table at 90–100 RPM) for 28 days. At days 1, 7, 14, and 28, the swelling ratio
and mass loss of the hydrogels were determined using the following equations: swelling ratio ¼ (Ws–
Wd)/Wd and % mass loss¼(Wi–Wd)/Wi100(%), where Wi, Ws, and Wd represent the weight of dried
hydrogel immediately following fabrication before swelling, the weight of wet hydrogel after swelling
at each time point, and the weight of dried hydrogel after swelling at each time point, respectively.
Main and interaction effects were analyzed using a linear regression analysis methodology according
to previously established methods [5,6]. Differences observed in the main and interaction effects
analysis were deemed signiﬁcant if their standard error did not cross the zero line.
2.2. Factorial analysis of hydrogel swelling and degradation
The data presented in Table 4 were derived from the main effects analysis of the swelling and
degradation of the various hydrogel formulations. A main effects and interactions analysis was per-
formed using the SAS JMP Pro 11 statistical software package, as permitted by the factorial design, in
order to formally examine the main effects of PLL MW and PLL loading amount on hydrogel swelling
and degradation from the complex dataset over time according to established methods [5]. As shown
in Table 4, the swelling of PLL-laden hydrogels was primarily affected by changes in the MW of the
incorporated PLL, where increases in average PLL MW from 50 to 225 kDa resulted in increased
swelling ratios at days 1 and 28. In addition to these main effects, several cross effects between the
factors of PLL MW, PLL loading, and OPF MW were also observed at various time points. Namely, the
swelling of hydrogels incorporating with PLL with an average MW of 225 kDa was more sensitive to
changes in PLL loading amount and OPF MW. Indeed, changing the PLL loading amount from a low to
a high level (AB interaction) and changing the OPF MW from a high to a low level (AC interaction) for
hydrogels incorporating 225 kDa PLL both resulted in greater decreases in equilibrium swelling ratios
when compared to formulations comprising 50 kDa PLL. Despite their effects on the swelling behavior
of PLL-laden hydrogels, the factors of PLL MW and PLL loading amount nominally affected hydrogel
degradation in general with the exception of several cross effects at day 7.
2.3. Assessment of cell viability encapsulated in OPF-PLL hydrogels
After characterizing the swelling and degradation of hydrogels, MSCs were then encapsulated into
PLL-laden OPF hydrogels and assessed for viability using LIVE/DEAD staining and ﬂuorescence
microscopy. Cell viability was determined and veriﬁed at 24 h and 7 days after encapsulation using
the Live/Dead staining assay (Life Technologies) following the manufacturer's instructions. Images
(Fig. 1) were obtained using ﬂuorescence microscopy (Nikon).Acknowledgements
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Supplementary data associated with this article can be found in the online version at http://dx.doi.
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